Boston Scientific Victory Creates Incentive To Settle Patent Dispute With J&J, Analysts Say

Law360, New York (July 5, 2005, 12:00 AM EDT) -- Medical device maker Boston Scientific Corp.’s victory last week in a patent lawsuit against Johnson & Johnson could help the company push through an agreement to settle the companies’ acrimonious battle over drug-coated coronary stents, analysts say.

On Friday, a federal jury in Delaware found that Johnson & Johnson's method for coating its Cypher stent with drugs infringed on a patent held by Boston Scientific.

The jury said that Boston Scientific's Ding patent covering drug coating had been infringed by Cypher and that the basic design...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.